{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:27:59Z","timestamp":1790918879343,"version":"4.1.0"},"publisher-location":"Vienna","reference-count":69,"publisher":"Springer Vienna","isbn-type":[{"value":"9783211735732","type":"print"},{"value":"9783211735749","type":"electronic"}],"license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007]]},"DOI":"10.1007\/978-3-211-73574-9_14","type":"book-chapter","created":{"date-parts":[[2007,12,27]],"date-time":"2007-12-27T13:43:42Z","timestamp":1198763022000},"page":"113-120","source":"Crossref","is-referenced-by-count":100,"title":["Biochemistry of postmortem brains in Parkinson\u2019s disease: historical overview and future prospects"],"prefix":"10.1007","author":[{"given":"T.","family":"Nagatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"14_CR1","first-page":"25","volume":"12","author":"P. Anglade","year":"1997","unstructured":"Anglade P, Vyas S, Javoy-Agid F, Ilerreto MT, Michel PP, Marquez J, Pouatt-Prigent A, Ruberg M, Hirsch C, Agid Y (1997) Apotosis and autophagy in nigral neurons of patients with Parkinson\u2019s disease. Histol Histopathol 12: 25\u201331","journal-title":"Histol Histopathol"},{"key":"14_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0304-3940(94)90684-X","volume":"172","author":"G. Boka","year":"1994","unstructured":"Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch H (1994) Immunocytochemical analysis of tumor necrosis factor and its receptor in Paekinson\u2019s disease. Neurosci Lett 172: 151\u2013154","journal-title":"Neurosci Lett"},{"key":"14_CR3","first-page":"89","volume":"70","author":"H Braak","year":"2006","unstructured":"Braak H, M\u00fcller CM, R\u00fcb U, Ackermann H, Bratzke H, de Vos Rai RAI, Del Tredici K (2006) Pathology associated with sporadic Parkinson\u2019s disease \u2014 where does it end? J Neural Transm Suppl 70: 89\u201397","journal-title":"J Neural Transm Suppl"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4615-1269-1_15","volume-title":"Neurotoxic factors in Parkinson\u2019s disease and related disorders","author":"G. Bringmann","year":"2000","unstructured":"Bringmann G, Br\u00fcckner R, M\u00fcnchbach M, Feinei D, God R, Wesemann W, Grote C, Herderich M, Diem S, Lesch K-P, M\u00f6ssner R, Storch A (2000) Clonal-derived mammalian alkaloid with neurotoxic properties. \u201cTaClo\u201d. In: Storch A, Collins MA (eds) Neurotoxic factors in Parkinson\u2019s disease and related disorders. Kluwer Academic Publishing\/Plenum, New York, pp 145\u2013149"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-4615-1269-1_13","volume-title":"Neurotoxic factors in Parkinson\u2019s disease and related disorders","author":"M.A. Collins","year":"2000","unstructured":"Collins MA, Neafsey El (2000) \u03b2-Carboline analogues of MPP+ as environmental neurotoxins. In: Storch MA, Collins MA (eds) Neurotoxic factors in Parkinson\u2019s disease and related disorders. Kluwer Academic Publishing\/Plenum, New York, pp 115\u2013130"},{"key":"14_CR6","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H. Ehringer","year":"1960","unstructured":"Ehringer H, Hornykiewicz O (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des Extrapyramidaren Systems. Klin Wochenschr 38: 1236\u20131239","journal-title":"Klin Wochenschr"},{"key":"14_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1353-8020(99)00043-7","volume":"6","author":"P. Foley","year":"2000","unstructured":"Foley P, Mizuno Y, Nagatsu T, Sano A, Youdim MBH, McGeer P, McGeer E, Riederer P (2000) The L-Dopa story \u2014 an early lapanese contribution. Parkinsonism Relat Disord 6: 1\u20131","journal-title":"Parkinsonism Relat Disord"},{"key":"14_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/326707a0","volume":"326","author":"B. Grima","year":"1987","unstructured":"Grima B, Lamouroux A, Boni C, Julien J-F, Javoy-Agid F, Mallet 1 (1987) A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature 326: 707\u2013711","journal-title":"Nature"},{"key":"14_CR9","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1073\/pnas.040556597","volume":"97","author":"A. Hartmann","year":"2000","unstructured":"Hartmann A, Hunot S, Michel PP, Muriel MP, Vyas S, Faucheux BA, Mouatt-Prignet A, Turmel H, Srinivasan A, Ruberg M, Evans GI, Agid Y, Hirsch EC (2000) Caspase-3: a vulnerable factor and a final effector in the apoptotic cell death of dopaminergic neurons in Parkinson\u2019s disease. Proc Natl Acad Sci USA 97: 2875\u20132880","journal-title":"Proc Natl Acad Sci USA"},{"key":"14_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0022-510X(01)00596-2","volume":"190","author":"H. Hashida","year":"2001","unstructured":"Hashida H, Goto J, Suzuki T, Jeong S-Y, Masuda N, Ooie T, Tachiiri Y, Tsuchiya H, Kanazawa I (2001) Single cell analysis of CAG repeat in brains of dentatorubral-pallidoluysian atrophy (DRPLA). J Neurol Sci 190: 87\u201393","journal-title":"J Neurol Sci"},{"key":"14_CR11","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1046\/j.1471-4159.2002.00881.x","volume":"81","author":"J.W. Haycock","year":"2002","unstructured":"Haycock JW (2002) Species differences in the expression of multiple tyrosine hydroxylase protein isoforms. J Neurochem 81: 974\u2013953","journal-title":"J Neurochem"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.2174\/1381612053381611","volume":"11","author":"S. Hayley","year":"2005","unstructured":"Hayley S, Anisman H (2005) Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: neurochemical and molecular substrates. Curr Pharmac Design 11: 947\u2013962","journal-title":"Curr Pharmac Design"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO;2-F","volume":"14","author":"E.C. Hirsch","year":"1999","unstructured":"Hirsch EC, Hunot S, Faucheux BA, Agid Y, Mizuno Y, Mochizuki H, Tatton WG, Tatton N, Olanow WC (1999) Dopaminergic neurons degenerate by apoptosis in Parkinson\u2019s disease. Mov Disord 14: 383\u2013385","journal-title":"Mov Disord"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","volume":"991","author":"E.C. Hirsch","year":"2003","unstructured":"Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP (2003) The role of glial reaction and inflammation in Parkinson\u2019s disease. Ann NY Acad Sci 991: 214\u2013228","journal-title":"Ann NY Acad Sci"},{"key":"14_CR15","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/S0006-291X(05)80933-7","volume":"173","author":"S. Ichikawa","year":"1990","unstructured":"Ichikawa S, Ichinose H, Nagatsu T (1990) Multiple mRNAs of monkey tyrosine hydroxylase. Biochem Biophys Res Commun 173: 1331\u20131336","journal-title":"Biochem Biophys Res Commun"},{"key":"14_CR16","doi-asserted-by":"publisher","first-page":"11546","DOI":"10.1021\/bi00161a036","volume":"31","author":"H. Ichinose","year":"1992","unstructured":"Ichinose H, Sumi-Ichinose C, Ohye T, Hagino Y, Fujit K, Nagatsu T (1992) Tissue-specific alternative splicing of the first exon generates two types of mRNAs in human aromatic L-amino acid decarboxylase. Biochemistry 31: 11546\u201311550","journal-title":"Biochemistry"},{"key":"14_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1006\/bbrc.1993.2024","volume":"195","author":"H. Ichinose","year":"1993","unstructured":"Ichinose H, Ohye T, Fujita K, Yoshida M, Ueda S, Nagatsu T (1993) Increased heterogeneity of tyrosine hydroxylase in humans. Biochem Biopys Res Commun 195: 158\u2013165","journal-title":"Biochem Biopys Res Commun"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/BF02250926","volume":"8","author":"H. Ichinose","year":"1994","unstructured":"Ichinose H, Ohye T, Fujita K, Pantucek F, Lange K, Riederer P, Nagatsu T (1994) Quantification of mRNA of tyrosine hydroxylase and aromatic L-amino acid decarboxylase in the substantia nigra in Parkinson\u2019s disease and schizophrenia. J Neural Transm [P-D Sect] 8: 149\u2013158","journal-title":"J Neural Transm [P-D Sect]"},{"key":"14_CR19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","volume":"106","author":"K. Imamura","year":"2003","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson\u2019s disease brain. Acta Neuropatholgica 106: 518\u2013526","journal-title":"Acta Neuropatholgica"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00401-004-0919-y","volume":"109","author":"K. Imamura","year":"2005","unstructured":"Imamura K, Hishikawa N, Ono K, Suzuki H, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2005) Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains. Acta Neuropathol 109: 141\u2013150","journal-title":"Acta Neuropathol"},{"key":"14_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s007020050001","volume":"107","author":"K.A. Jellinger","year":"2005","unstructured":"Jellinger KA (2005) Cell death mechanism in Parkinson\u2019s disease. J Neural Transm 107: 1\u201329","journal-title":"J Neural Transm"},{"key":"14_CR22","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0006-291X(87)90742-X","volume":"146","author":"N. Kaneda","year":"1987","unstructured":"Kaneda N, Kobayashi K, Ichinose H, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T (1987) Isolation of a novel cDNA clone for human tyrosine hydroxylase: alternative RNA splicing produces four kinds of mRNA from a single gene. Biochem Biophys Res Commun 146: 971\u2013975","journal-title":"Biochem Biophys Res Commun"},{"key":"14_CR23","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1046\/j.1471-4159.2003.01703.x","volume":"85","author":"Y. Kawahara","year":"2003","unstructured":"Kawahara Y, Kwak S, Sun H, Ito K, Hashida H, Aizawa H, Jeong S-Y, Kanazawa I (2003) Human spinal motoneurons express low relative abundance of GluR2 mRNA: an implication for exicitotoxicity in ALS. J Neurochem 85: 680\u2013689","journal-title":"J Neurochem"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/oxfordjournals.jbchem.a122386","volume":"103","author":"K. Kobayashi","year":"1988","unstructured":"Kobayashi K, Kaneda N, Ichinose H, Kishi F, Nakazawa A, Kurosawa Y, Fujita K, Nagatsu T (1988) Structure of the human tyrosine hydrox-ylase gene: alternative splicing from a single gene accounts for generation of four mRNA types. J Biochem 103: 907\u2013912","journal-title":"J Biochem"},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1046\/j.1471-4159.1995.65062633.x","volume":"65","author":"Y. Kotake","year":"1995","unstructured":"Kotake Y, Tasaki Y, Makino S, Ohta S, Hirobe M (1995) l-Benzyl-1,2,3,4-tetrahydroisoquinoline as a parkinsonism-inducing agent: a novel endogenous amine in mouse brain and parkinsonian CSF. J Neurochem 65: 2633\u20132638","journal-title":"J Neurochem"},{"key":"14_CR26","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","volume":"219","author":"J.W. Langsten","year":"1983","unstructured":"Langsten JW, Ballard P, Tetrad JW, Irwin I (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219: 979\u2013980","journal-title":"Science"},{"key":"14_CR27","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","volume":"46","author":"J.W. Langsten","year":"1999","unstructured":"Langsten JW, Forno JS, Tetrad J, Reeves AG, Kaplan JA, Karluk D (1999) Evidence of active nerve cell degeneration in the substantia nigra of humans years after l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine exposure. Ann Neurol 46: 598\u2013605","journal-title":"Ann Neurol"},{"key":"14_CR28","first-page":"1075","volume":"171","author":"K. Lloyd","year":"1970","unstructured":"Lloyd K, Hornykiewicz O (1970) Parkinson\u2019s disease: activity of L-DOPA decarboxylase in discrete brain regions. Science 171: 1075\u20131078","journal-title":"Science"},{"key":"14_CR29","first-page":"453","volume":"195","author":"K.G. Lloyd","year":"1975","unstructured":"Lloyd KG, Davidson L, Hornykiewicz O (1975) The neurochemistry of Parkinson\u2019s disease: effect of L-dopa therapy. J Pharmacol Exp Ther 195: 453\u2013464","journal-title":"J Pharmacol Exp Ther"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-4615-1269-1_14","volume-title":"Neurotoxic factors in Parkinson\u2019s disease and related disorders","author":"K. Matsubara","year":"2000","unstructured":"Matsubara K (2000) N-Methyl-\u03b2-carbolinium neurotoxins in Parkinson\u2019s disease. In: Storch A, Collins MA (eds) Neurotoxic factors in Parkinson\u2019s disease and related disorders. Kluwer Academic Publishing\/ Plenum, New York, pp 131\u2013143"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1471-4159.1976.tb04437.x","volume":"26","author":"P.L. McGeer","year":"1976","unstructured":"McGeer PL, McGeer EG (1976) Enzymes associated with the metabolism of catecholamine, acetylcholine and GABA in human controls and patients with Parkinson\u2019s disease and Huntington\u2019s chorea. J Neurochem 26: 65\u201376","journal-title":"J Neurochem"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","volume":"38","author":"P.L. McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s disease and Alzheimer\u2019s disease brains. Neurology 38: 1285\u20131291","journal-title":"Neurology"},{"key":"14_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"P.L. McGeer","year":"1995","unstructured":"McGeer PL, McGeer EG (1995) The inflammatory response system of brain, implications for therapy of Alzheimer\u2019s and other neurodegenetative diseases. Brain Res Rev 21: 195\u2013218","journal-title":"Brain Res Rev"},{"key":"14_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ana.10728","volume":"54","author":"P.L. McGeer","year":"2003","unstructured":"McGeer PL, Schwab C, Parent A, Doudet D (2003) Presence of reactive microglia in monkey substantia nigra years after l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann Neurol 54: 599\u2013604","journal-title":"Ann Neurol"},{"key":"14_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-3-211-45295-0_30","volume":"70","author":"Y. Mizuno","year":"2006","unstructured":"Mizuno Y, Hattori N, Yoshino H, Hatano Y, Satoh K, Tomiyama H, Li Y (2006) Progress in familial Parkinson\u2019s disease. J Neural Transm Suppl 70: 191\u2013204","journal-title":"J Neural Transm Suppl"},{"key":"14_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF01244634","volume":"72","author":"M. Mogi","year":"1988","unstructured":"Mogi M, Harada M, Kiuchi K, Kojima K, Kondo T, Narabayashi H, Rausch D, Riederer P, Jellinger K, Nagatsu T (1988a) Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in Parkinsonian brain. J Neural Transm 72: 77\u201381","journal-title":"J Neural Transm"},{"key":"14_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0197-0186(88)90126-X","volume":"12","author":"M. Mogi","year":"1988","unstructured":"Mogi M, Harada M, Kojima K, Inagaki H, Kondo T, Narabayashi H, Arai T, Teradaira R, Fujita K, Kiuchi K, Nagatsu T (1988b) Sandwich enzyme immunoassay of dopamine-\u03b2-hydroxylase in cerebrospinal fluid from control and Parkinsonian patients. Neurochem Int 12: 187\u2013191","journal-title":"Neurochem Int"},{"key":"14_CR38","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","volume":"165","author":"M. Mogi","year":"1994","unstructured":"Mogi M, Harada M, Riederer P, Narabayashi H, Fuita K, Nagatsu T (1994) Tumor necrosis factor-\u03b1 (TNF-\u03b1) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci Lett 165: 208\u2013210","journal-title":"Neurosci Lett"},{"key":"14_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3940(98)00427-3","volume":"250","author":"M. Mogi","year":"1998","unstructured":"Mogi M, Togari A, Ogawa M, Ikeguchi K, Shizuma N, Fan D-S, Nakano I, Nagatsu T (1998) Effects of repeated systemic administration of l-methyl-4-phenyl-l,2,3,6-tetrahydripyridine (MPTP) to mice on interleukin-1 \u03b2 and nerve growth factor in the striatum. Neurosci Lett 250: 25\u201328","journal-title":"Neurosci Lett"},{"key":"14_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0304-3940(00)01275-1","volume":"289","author":"M. Mogi","year":"1999","unstructured":"Mogi M, Togari A, Tanaka K, Ogawa N, Ichinose H, Nagatsu T (1999) Increase in level of tumor necrosis factor (TNF)-\u03b1 in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosupressant FK506. Neurosci Lett 289: 165\u2013168","journal-title":"Neurosci Lett"},{"key":"14_CR41","first-page":"135","volume":"80","author":"M. Mogi","year":"1999","unstructured":"Mogi M, Nagatsu T (1999) Neurotrophins and cytokines in Parkinson\u2019s disease. Adv Neurol 80: 135\u2013139","journal-title":"Adv Neurol"},{"key":"14_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s007020050028","volume":"107","author":"M. Mogi","year":"2000","unstructured":"Mogi M, Togari A, Kondo T, Mizuno Y, Komure O, Kuno S, Ichinose H, Nagatsuu T (2000) Caspase activities and tumor necrosis-\u03b1 Rl (p55) level were elevated in the subsantia nigra from Parkinsonian brain. J Neural Transm 107: 335\u2013341","journal-title":"J Neural Transm"},{"key":"14_CR43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0009-8981(77)90193-0","volume":"75","author":"T. Nagatsu","year":"1977","unstructured":"Nagatsu T, Kato T, Numata (Sudo) Y, Ikuta K, Sano M, Nagatsu I, Kondo Y, Inagaki S, Iizuka R, Hori A, Narabayashi H (1977) Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain. Clin Chim Acta 75: 221\u2013232","journal-title":"Clin Chim Acta"},{"key":"14_CR44","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0009-8981(81)90316-8","volume":"109","author":"T. Nagatsu","year":"1981","unstructured":"Nagatsu T, Yamaguchi T, Kato T, Sugimoto T, Matsuura S, Akino M, Nagatsu I, Iizuka R, Narabayashi H (1981) Biopterin in human brain and urine from controls and parkinsonian patients: application of a new radioimmunoassay. Clin Chim Acta 109: 305\u2013311","journal-title":"Clin Chim Acta"},{"key":"14_CR45","first-page":"467","volume":"40","author":"T. Nagatsu","year":"1984","unstructured":"Nagatsu T, Yamaguchi T, Rahman MK, Trocewicz J, Oka K, Hirata Y, Nagatsu I, Narabayashi H, Kondo T, Iizuka R (1984) Catecholamine related-enzymes and the biopterin cofactor in Parkinson\u2019s disease. Adv Neurol 40: 467\u2013473","journal-title":"Adv Neurol"},{"key":"14_CR46","first-page":"223","volume":"45","author":"T. Nagatsu","year":"1986","unstructured":"Nagatsu T, Horikoshi T, Sawada M, Nagatsu I, Kondo T, Iizuka R, Narabayashi H (1986) Biosynthesis of tetrahydrobiopterin in parkinsonian human brain. Adv Neurol 45: 223\u2013226","journal-title":"Adv Neurol"},{"key":"14_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0165-9936(88)80026-8","volume":"7","author":"T. Nagatsu","year":"1988","unstructured":"Nagatsu T, Kojima K (1988) Application of electrochemical detection in high-performance liquid chromatography to the assay of biologically active compounds. Trend Anal Chem 7: 21\u201327","journal-title":"Trend Anal Chem"},{"key":"14_CR48","first-page":"207","volume":"53","author":"T. Nagatau","year":"1990","unstructured":"Nagatau T (1990) Changes in tyrosine hydroxylase in parkinsonian brains and in the brain of MPTP-treated mice. Adv Neurol 53: 207\u2013214","journal-title":"Adv Neurol"},{"key":"14_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0168-0102(97)00083-7","volume":"29","author":"T. Nagatsu","year":"1997","unstructured":"Nagatsu T (1997) Isoquinoline neurotoxins in the brain and Parkinson\u2019s disease. Neurosci Res 29: 99\u2013111","journal-title":"Neurosci Res"},{"key":"14_CR50","first-page":"88","volume":"2","author":"T. Nagatsu","year":"1999","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari A, Riederer P (1999) Cytokines in Parkinson\u2019s disease. Neurosci News 2: 88\u201390","journal-title":"Neurosci News"},{"key":"14_CR51","first-page":"143","volume":"58","author":"T. Nagatsu","year":"2000","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari F (2000a) Cytokines in Parkinson\u2019s disease. J Neural Transm Suppl 58: 143\u2013151","journal-title":"J Neural Transm Suppl"},{"issue":"60","key":"14_CR52","first-page":"277","volume":"60","author":"T. Nagatsu","year":"2000","unstructured":"Nagatsu T, Mogi M, Ichinose H, Togari F (2000b) Changes in cytokines and neurotrophins in Parkinson\u2019s disease. J Neural Transm 60: 277\u2013290 Suppl 60: 277\u2013290","journal-title":"J Neural Transm"},{"key":"14_CR53","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0892-0362(02)00209-X","volume":"24","author":"T. Nagatsu","year":"2002","unstructured":"Nagatsu T (2002a) Amine-related neurotoxins in Parkinson\u2019s disease: past, present, and future. Neurotoxicol Teratol 24: 565\u2013569","journal-title":"Neurotoxicol Teratol"},{"key":"14_CR54","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s007020200061","volume":"109","author":"T. Nagatsu","year":"2002","unstructured":"Nagatsu T (2002b) Parkinson\u2019s disease: changes in apoptosis-related factors suggesting possible gene therapy. J Neural Transm 109: 731\u2013745","journal-title":"J Neural Transm"},{"key":"14_CR55","doi-asserted-by":"publisher","first-page":"999","DOI":"10.2174\/1381612053381620","volume":"11","author":"T. Nagatsu","year":"2005","unstructured":"Nagatsu T, Sawada M (2005) Inflammatory process in Parkinson\u2019s disease: role for cytokines. Curr Pharmaceut Design 11: 999\u20131016","journal-title":"Curr Pharmaceut Design"},{"key":"14_CR56","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s10571-006-9061-9","volume":"26","author":"T. Nagatsu","year":"2006","unstructured":"Nagatsu T, Sawada M (2006) Cellular and molecular mechanisms of Parkinson\u2019s disease: neurotoxins, causative genes, and inflammatory cytokines. Cell Mol Neurobiol 26: 779\u2013800","journal-title":"Cell Mol Neurobiol"},{"key":"14_CR57","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0006-8993(95)01325-3","volume":"709","author":"M. Naoi","year":"1996","unstructured":"Naoi M, Maruyama W, Dostert P, Hashizume Y, Nakahara D, Takahashi T, Ota M (1996) Dopamine-derived endogenous 1(R), 2(N)-dimethyl-6,7-dihydroxy-l,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rats: biochemical, pathological and behavioral studies. Brain Res 709: 285\u2013295","journal-title":"Brain Res"},{"key":"14_CR58","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1006\/neur.1995.0009","volume":"4","author":"T. Ohye","year":"1995","unstructured":"Ohye T, Ichinose H, Ogawa M, Yoshida M, Nagatsu T (1995) Alterations in multiple tyrosine hydroxylase mRNAs in the substantia nigra, locus coeruleus and adrenal gland of MPTP-treated Parkinsonian monkeys. Neurodegeneation 4: 81\u201385","journal-title":"Neurodegeneation"},{"key":"14_CR59","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1471-4159.1988.tb13250.x","volume":"50","author":"W.-D. Rausch","year":"1988","unstructured":"Rausch W-D, Hirata Y, Nagatsu T, Riederer P, Jellinger K (1988) Tyrosine hydroxylase activity in caudate nucleus from Parkinson\u2019s disease: effects of iron and phosphorylating agents. J Neurochem 50: 202\u2013208","journal-title":"J Neurochem"},{"key":"14_CR60","first-page":"121","volume":"14","author":"P. Riederer","year":"1978","unstructured":"Riederer P, Rausch W-D, Birkmayer W, Jellinger K, Seemann D (1978) CNS modulation of adrenal tyrosine hydroxylase in Parkinson\u2019s disease and metabolic encepahlopathies. J Neural Transm Suppl 14: 121\u2013131","journal-title":"J Neural Transm Suppl"},{"key":"14_CR61","first-page":"125","volume-title":"Parkinson\u2019s disease: Adv Neurol 86","author":"P. Riederer","year":"2001","unstructured":"Riederer P, Reichmann H, Janetzky B, Sian J, Lesch K-P, Lange KW, Double KL, Nagatsu T, Gerlach M (2001) Neural degeneration in Parkinson\u2019s disease. In: Calne D, Calne S (eds) Parkinson\u2019s disease: Adv Neurol 86. Lippincott Williams & Wilkins, Philadelphia, pp 125\u2013136"},{"key":"14_CR62","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-1-59259-297-5_21","volume-title":"Neuroinflammation","author":"J. Rogers","year":"2003","unstructured":"Rogers J, Kovelowski CJ (2003) Inflammatory mechanisms in Parkinson\u2019s disease. In: Wood PL (ed) Neuroinflammation. Humana Press, Totowa, New lersey, pp 391\u2013403"},{"key":"14_CR63","first-page":"42","volume":"5","author":"I. Sano","year":"1960","unstructured":"Sano I (1960) Biochemistry of the extrapyramidal system. Shinkei Kenyu No Shinnpo (Adv Neurol Sci) 5: 42\u201348; Translated into English (by","journal-title":"Shinkei Kenyu No Shinnpo (Adv Neurol Sci)"},{"key":"14_CR64","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S1353-8020(99)00046-2","volume":"6","author":"A. Sano","year":"2000","unstructured":"Sano A (2000) Parkinsonism Relat Disord 6: 303\u2013306","journal-title":"Parkinsonism Relat Disord"},{"key":"14_CR65","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF01260420","volume":"62","author":"M. Sawada","year":"1985","unstructured":"Sawada M, Nagatsu T, Nagatsu I, Ito K, Iizuka R, Kondo T, Narabayashi H (1985) Tryptophan hydroxylase activity in the brains of controls and parkinsonian patients. J Neural Transm 62: 107\u2013115","journal-title":"J Neural Transm"},{"key":"14_CR66","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1471-4159.1987.tb05582.x","volume":"48","author":"M. Sawada","year":"1987","unstructured":"Sawada M, Hirata Y, Arai H, Iizuka R, Nagatsu T (1987) Tyrosine hydroxylase, tryptophan hydroxylase, biopterin, and neopterin in the brains of normal controls and patients with senile dementia of Alzheimer type. J Neurochem 48: 760\u2013764","journal-title":"J Neurochem"},{"key":"14_CR67","first-page":"373","volume":"70","author":"M. Sawada","year":"2006","unstructured":"Sawada M, Imamura K, Nagatsu T (2006) Role of cytokines in inflammatory process in Parkinson\u2019s disease. J Neural Transm Suppl 70: 373\u2013381","journal-title":"J Neural Transm Suppl"},{"key":"14_CR68","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/0006-2944(82)90036-9","volume":"27","author":"J. Trocewicz","year":"1982","unstructured":"Trocewicz J, Oka K, Nagatsu T, Nagatsu I, Iizuka R, Narabayashi H (1982) Phenylethanolamine N-methyltransferase activity in human brains. Biochem Med 27: 317\u2013324","journal-title":"Biochem Med"},{"key":"14_CR69","doi-asserted-by":"publisher","first-page":"42136","DOI":"10.1074\/jbc.M200862200","volume":"277","author":"F. Vilhardt","year":"2002","unstructured":"Vilhardt F, Piastre O, Sawada M, Suzuki K, Wiznerowicz M, Kiyokawa E, Trono D, Krause K-H (2002) The HIV-1 Nef protein and phagocyte NADPH oxidase activation. J Biol Chem 277: 42136\u201342143","journal-title":"J Biol Chem"}],"container-title":["Neuropsychiatric Disorders An Integrative Approach"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-211-73574-9_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T16:23:13Z","timestamp":1737735793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-211-73574-9_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"ISBN":["9783211735732","9783211735749"],"references-count":69,"URL":"https:\/\/doi.org\/10.1007\/978-3-211-73574-9_14","relation":{},"subject":[],"published":{"date-parts":[[2007]]}}}